The Prevalence of Aortic Stenosis in the Elderly in Iceland and Predictions for the Coming Decades: the AGES-Reykjavík Study

Overview

Journal Int J Cardiol

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2014 Aug 31

PMID 25171970

Citations 50

Authors

Ragnar Danielsen

Thor Aspelund

Tamara B Harris

Vilmundur Gudnason

Affiliations

Soon will be listed here.

Abstract

Aims: To evaluate the prevalence of significant aortic valve stenosis (AS) in a randomly selected study population of elderly individuals representing the general population of Iceland. Furthermore, to predict the number of individuals likely to have severe AS in the future.

Methods And Results: Echocardiography and computed tomography (CT) data from individuals who participated in the AGES-Reykjavik study were used. Echocardiography data from 685 individuals (58% females) aged 67-95 years were available. In both sexes combined, the prevalence for severe AS, defined as an aortic valve area index of <0.6 cm2/m2, in the age groups<70, 70-79 and ≥80 years was 0.92%, 2.4% and 7.3%, respectively. A ROC analysis on the relation between the echocardiography data and the aortic valve calcium score on CT defined a score≥500 to be indicative of severe AS. Subsequently, in a CT study cohort of 5256 individuals the prevalence of severe AS in the same age groups was 0.80%, 4.0% and 9.5%, respectively. Overall, the prevalence of severe AS by echocardiography and CT in individuals≥70 years was 4.3% and 5.9%, respectively. A prediction on the number of elderly≥70 years for the coming decades demonstrated that patients with severe AS will have increased 2.4 fold by the year 2040 and will more than triple by the year 2060.

Conclusion: This study, in a cohort of elderly individuals representative of the general population in a Nordic country, predicts that AS will be a large health problem in the coming decades.

Citing Articles

Predictors of the diuretic response in acute decompensated heart failure patients with severe aortic stenosis: sub-analysis of the LOHAS registry.

Takada T, Jujo K, Abe T, Shimazaki K, Nara Y, Hioki H Cardiovasc Interv Ther. 2025; .

PMID: 39934604 DOI: 10.1007/s12928-025-01100-1.

Contemporary Management of the Aortic Valve-Narrative Review of an Evolving Landscape.

Lella S, Ferrell B, Sugiura T J Clin Med. 2025; 14(1.

PMID: 39797217 PMC: 11722002. DOI: 10.3390/jcm14010134.

Giant Right Atrial Myxoma Coexisting With Tricuspid Regurgitation, Coronary Artery Disease, and Aortic Stenosis.

Takahashi B, Momsila P, Isa H, Arayawudhikul N Cureus. 2025; 16(12):e75311.

PMID: 39776748 PMC: 11706099. DOI: 10.7759/cureus.75311.

Calcific aortic stenosis: omics-based target discovery and therapy development.

Blaser M, Back M, Luscher T, Aikawa E Eur Heart J. 2024; 46(7):620-634.

PMID: 39656785 PMC: 11825147. DOI: 10.1093/eurheartj/ehae829.

Effect of Glucagon-like Peptide-1 Receptor Agonism on Aortic Valve Stenosis Risk: A Mendelian Randomization Analysis.

Karakasis P, Patoulias D, Giannakoulas G, Sagris M, Theofilis P, Fragakis N J Clin Med. 2024; 13(21).

PMID: 39518550 PMC: 11546526. DOI: 10.3390/jcm13216411.

References

Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P . Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J. 2005; 26(24):2714-20. DOI: 10.1093/eurheartj/ehi471. View

Thanassoulis G, Campbell C, Owens D, Smith J, Smith A, Peloso G . Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013; 368(6):503-12. PMC: 3766627. DOI: 10.1056/NEJMoa1109034. View

Berry C, Lloyd S, Wang Y, Macdonald A, Ford I . The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. Eur Heart J. 2012; 34(21):1538-47. DOI: 10.1093/eurheartj/ehs339. View

Vahanian A, Alfieri O, Andreotti F, Antunes M, Baron-Esquivias G, Baumgartner H . Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012; 42(4):S1-44. DOI: 10.1093/ejcts/ezs455. View

Osnabrugge R, Head S, Bogers A, Kappetein P . Patient selection for transcatheter aortic valve replacement: what does the future hold?. Expert Rev Cardiovasc Ther. 2012; 10(6):679-81. DOI: 10.1586/erc.12.54. View

Sverdlov A, Ngo D, Chan W, Chirkov Y, Gersh B, McNeil J . Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics. Eur Heart J. 2012; 33(19):2419-25. DOI: 10.1093/eurheartj/ehs171. View

Iung B, Baron G, Butchart E, Delahaye F, Gohlke-Barwolf C, Levang O . A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24(13):1231-43. DOI: 10.1016/s0195-668x(03)00201-x. View

Danielsen R, Nordrehaug J . Clinical and haemodynamic features in relation to severity of aortic stenosis in adults. Eur Heart J. 1991; 12(7):791-5. DOI: 10.1093/eurheartj/12.7.791. View

Hekimian G, Boutten A, Flamant M, Duval X, Dehoux M, Benessiano J . Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study. Eur Heart J. 2013; 34(25):1915-22. DOI: 10.1093/eurheartj/ehs450. View

10.

Harris T, Launer L, Eiriksdottir G, Kjartansson O, Jonsson P, Sigurdsson G . Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol. 2007; 165(9):1076-87. PMC: 2723948. DOI: 10.1093/aje/kwk115. View

11.

Muraru D, Badano L, Vannan M, Iliceto S . Assessment of aortic valve complex by three-dimensional echocardiography: a framework for its effective application in clinical practice. Eur Heart J Cardiovasc Imaging. 2012; 13(7):541-55. DOI: 10.1093/ehjci/jes075. View

12.

Eveborn G, Schirmer H, Heggelund G, Lunde P, Rasmussen K . The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart. 2012; 99(6):396-400. DOI: 10.1136/heartjnl-2012-302265. View

13.

Lindroos M, Kupari M, Heikkila J, Tilvis R . Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993; 21(5):1220-5. DOI: 10.1016/0735-1097(93)90249-z. View

14.

Koos R, Kuhl H, Muhlenbruch G, Wildberger J, Gunther R, Mahnken A . Prevalence and clinical importance of aortic valve calcification detected incidentally on CT scans: comparison with echocardiography. Radiology. 2006; 241(1):76-82. DOI: 10.1148/radiol.2411051163. View

15.

Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607. DOI: 10.1056/NEJMoa1008232. View

16.

Bonow R . Improving outlook for elderly patients with aortic stenosis. JAMA. 2013; 310(19):2045-7. DOI: 10.1001/jama.2013.281825. View

17.

Stefansdottir H, Aspelund T, Gudnason V, Arnar D . Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace. 2011; 13(8):1110-7. DOI: 10.1093/europace/eur132. View

18.

Stewart B, Siscovick D, Lind B, Gardin J, Gottdiener J, Smith V . Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997; 29(3):630-4. DOI: 10.1016/s0735-1097(96)00563-3. View

19.

Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S . Natural history of very severe aortic stenosis. Circulation. 2009; 121(1):151-6. DOI: 10.1161/CIRCULATIONAHA.109.894170. View

20.

Bahlmann E, Gerdts E, Cramariuc D, Gohlke-Baerwolf C, Nienaber C, Wachtell K . Prognostic value of energy loss index in asymptomatic aortic stenosis. Circulation. 2013; 127(10):1149-56. DOI: 10.1161/CIRCULATIONAHA.112.078857. View